Chinese Guidelines for the Prevention and Management of Bipolar Disorders (Third version)

Title: Chinese Guidelines for the Prevention and Management of Bipolar Disorders (Third version)
Edition: Updated
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Psychiatrists, General physicians, Clinical pharmacists, Nurses, Researchers, Medical school teachers, Psychological consultants, Rehabilitation physiatrists
Evidence classification method: 1级:至少2项重复的双盲随机对照试验,包括安慰剂或者阳性对照(治疗组例数至少超过30例),或具有窄置信区间的荟萃分析 2级:至少1项双盲随机对照试验,包括安慰剂或者阳性对照(治疗组例数至少超过30例),或具有宽置信区间的荟萃分析 3级:至少1项双盲随机对照试验,包括安慰剂或者阳性对照(治疗组例数在10-29例之间),或高质量的回顾性研究 4级:开放标签试验,前瞻性非随机对照试验,病例报告,专家建议/共识
Development unit: Chinese Society of Psychiatry
Registration time: 2023-05-25
Registration number: PREPARE-2023CN360
Purpose of the guideline: The Chinese Society of Psychiatry (CSP) published the first and second versions of the Chinese guidelines for the prevention and management of bipolar disorder in 2007 and 2015, respectively. The second version of the Chinese guidelines for bipolar disorder has received positive responses from domestic psychiatrists and scholars and has been widely used in clinical practice in China. The pragmatic guidelines have been reprinted twice for clinical use. In addition, the introduction of the guidelines has been published in BIPOLAR DISORDERS, which acquaints clinicians and specialists around the world with Chinese practice in bipolar disorder. With the rapid development of psychiatry, more and more attention has been attracted to the bipolar field, and new evidence accumulates rapidly. In the context of evidence-based clinical practice, worldwide countries/regions/societies have been updating the management of patients with bipolar disorder, including CANMAT/ISBD、BAP、CINP, et al. Meanwhile, comprehensive progress in bipolar disorder has been made in China, including pathogenesis, assessment, diagnoses, and treatments. Particular patients with bipolar disorders, like children and adolescents and patients comorbid with other medical conditions, have been widely studied and discussed in China. In recent years, China has published a series of consensus, suggestions, and precise guidelines for bipolar disorder. New approaches to the assessment and management of bipolar disorder constantly emerge based on the advances in clinical medicine and interdisciplinarity, such as brain-computer interface, artificial intelligence, and big data analysis. In summary, it is imperative to republish the Chinese guidelines for the prevention and management of bipolar disorder to provide more appropriate, effective, and up-to-date diagnosis and treatment strategies for Chinese psychiatric practice.